Differentiating Acute Hepatitis B from the First Episode of Symptomatic Exacerbation of Chronic Hepatitis B

In countries with intermediate or high endemicity for chronic hepatitis B virus (HBV) infection, exacerbations of chronic hepatitis B (CHB) are common. We studied the clinical, biochemical, and virologic characteristics of patients first presenting clinically with features of acute icteric hepatitis B, to identify features that might differentiate between acute viral hepatitis B (AVHB) from first episode of exacerbation of chronic hepatitis (ECHB). We retrospectively analyzed 79 patients (mean age 35.4 ± 14 years; M:F = 60:19) who first presented clinically as AVHB, within 4 weeks of onset of symptoms. Patients who on follow-up cleared HBsAg and/or did not develop any clinical, radiologic, or histologic evidence of chronic liver disease (CLD) were categorized as AVHB (group 1). Patients who had persistence of HBsAg and developed clinical, biochemical, radiologic, or histologic evidence of chronic liver disease were categorized as ECHB (group 2). Forty-nine patients were in group 1 and 30 in group 2. The 2 groups were comparable with respect to prodrome, onset of jaundice, serum bilirubin, ALT, prothrombin time prolongation, serum albumin, and A/G ratio. Among group 1 patients, 78% had IgM anti-HBc positive in titers > 1:1000; in group 2, there were negative or positive in titers < 1:1000 in 70% patients (P < .001). Forty-seven of 49 (95.9%) patients in group 1 had HBV-DNA levels < 0.5 pg/mL, whereas 26 of 30 (86.73%) patients in group 2 had levels > 0.5 pg/mL (P ≤ .001). Quantitative HBV DNA and IgM anti-HBc titers at initial presentation can differentiate patients with a true episode of acute hepatitis B from patients with first episode of symptomatic exacerbation of chronic hepatitis B. Clinical and biochemical features do not help in differentiating the two.

[1]  J. Cianciara,et al.  Immunoglobulin classes of antibody to hepatitis B core antigen. , 1975, The Journal of infectious diseases.

[2]  A. Redeker Viral hepatitis: clinical aspects. , 1975, The American journal of the medical sciences.

[3]  W. Bancroft,et al.  IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. , 1981, The Journal of infectious diseases.

[4]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[5]  C. Chu,et al.  The etiology of acute viral hepatitis in an endemic area of hepatitis A and B. , 1983, The American journal of tropical medicine and hygiene.

[6]  P. Stathopoulou,et al.  Diagnostic value of anti‐HBc IgM in high hbv prevalence areas , 1984, Journal of medical virology.

[7]  J. Hoofnagle,et al.  Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. , 1985, Annals of internal medicine.

[8]  S. Sherlock,et al.  The natural history of hepatitis B. , 1987, Postgraduate medical journal.

[9]  R. Purcell,et al.  Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. , 1987, Gastroenterology.

[10]  P. Marcellin,et al.  Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B , 1990, Hepatology.

[11]  Sanjeev Gupta,et al.  Spontaneous Reactivation in Chronic Hepatitis B: Patterns and Natural History , 1990, Journal of clinical gastroenterology.

[12]  C. Rogler,et al.  Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. , 1991, Current topics in microbiology and immunology.

[13]  F. Chisari Analysis of hepadnavirus gene expression, biology, and pathogenesis in the transgenic mouse. , 1991, Current topics in microbiology and immunology.

[14]  M. Loriot,et al.  Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B. , 1992, Journal of Hepatology.

[15]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[16]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[17]  Valeer J Desmet,et al.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. , 2003, Journal of hepatology.

[18]  Y. Liaw,et al.  Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update * , 2003, Journal of gastroenterology and hepatology.

[19]  L. Seeff Natural history of hepatitis C , 1997, Clinics in liver disease.

[20]  Y. Liaw,et al.  The aetiology of acute hepatitis in Taiwan: Acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate , 1988, Infection.